Lopez-Acevedo, M., Grace, L., Teoh, D., Whitaker, R., Adams, D. J., Jia, J., . . . Secord, A. A. (2014). Dasatinib (BMS-35482) potentiates the activity of gemcitabine and docetaxel in uterine leiomyosarcoma cell lines. Gynecol Oncol Res Pract.

Lopez-Acevedo, Micael, Lisa Grace, Deanna Teoh, Regina Whitaker, David J. Adams, Jingquan Jia, Andrew B. Nixon, a Angeles Alvarez Secord. "Dasatinib (BMS-35482) Potentiates the Activity of Gemcitabine and Docetaxel in Uterine Leiomyosarcoma Cell Lines." Gynecol Oncol Res Pract 2014.

Lopez-Acevedo, Micael, et al. "Dasatinib (BMS-35482) Potentiates the Activity of Gemcitabine and Docetaxel in Uterine Leiomyosarcoma Cell Lines." Gynecol Oncol Res Pract 2014.